Immunotherapy Industry, March 2015 Market Reports from Top Publishers

You might be interested in: therapeutics, cancer, medical equipment, drug, cancer drug, cancer immunotherapy, alzheimer's disease, biotherapeutics, cancer centre, cancer therapeutics, drug delivery, lymphoma, allergic rhinitis, arthritis, atherosclerosis.


 
1-10 of 49 reports for Immunotherapy

Respiratory Therapy News FEBRUARY 2015

Respiratory Therapy News FEBRUARY 2015

  • $ 1 114
  • Industry report
  • February 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - AstraZeneca Further Bolsters Respiratory Portfolio Industry Trend Analysis - IPF ODD Status Advances PBI-4050 Toward Success Industry Brief - GSK Launches Two Products In US Fo ...

SLIT Tablets, Self-Administration, and Allergy Immunotherapy to 2022 : Products, Players, Markets, and Forecasts

SLIT Tablets, Self-Administration, and Allergy Immunotherapy to 2022 : Products, Players, Markets, and Forecasts

  • $ 2 850
  • Industry report
  • February 2015
  • by Greystone Research Associates

Immunotherapy involves the administration of gradually increasing doses of the allergen over a period of time to desensitize the patient. It is the only known treatment that modifies the immune response ...

Immunotherapy in Oncology: Drug Pathway Analyzer 2015

Immunotherapy in Oncology: Drug Pathway Analyzer 2015

  • $ 3 675
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 906 immunotherapy drugs known to affect more than 235 specific intracellular signaling pathways for the ...

Opexa Therapeutics, Inc. (Symbol:OPXA) SWOT Analysis, Strategy, Revenues and Profits

Opexa Therapeutics, Inc. (Symbol:OPXA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary bluebird bio, Inc. (bluebird bio) is a biotechnology company. The company develops gene therapies for severe genetic and orphan diseases. Its products include LentiGlobin, Lenti D, and CAR T cells. ...

Immunotherapy in Oncology Drug Pipeline Update 2015

Immunotherapy in Oncology Drug Pipeline Update 2015

  • $ 3 675
  • Industry report
  • January 2015
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

BioSeeker's Targeting Immune Checkpoints in Cancer Immunotherapy: Drug Pipeline Update is the most up to date and comprehensive pipeline review and competitive assessment you can get on this hot and fast ...

MediGene AG (Symbol:MDG) SWOT Analysis, Strategy, Revenues and Profits

MediGene AG (Symbol:MDG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • December 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Genitope Corporation (Genitope) is a publicly held US based biotechnology company. It is focused on the research and development (R&D) of novel immunotherapies for the treatment of cancer. The ...

Oncothyreon Inc. (ONTY) - Financial and Strategic SWOT Analysis Review

Oncothyreon Inc. (ONTY) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Oncothyreon Inc. (Oncothyreon) is a biotechnology company. It focuses on developing therapeutic products for the cancer treatment. The company offers both synthetic vaccines and targeted small ...

About 800 reports for Immunotherapy

Download Unlimited Documents from Trusted Public Sources

Medinet Annual Report 2013

  • January 2013
    171 pages
  • Equity Market  

    Preferred Stock  

    Common Stock  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.